Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'rnai ' returned 88 results - Page 1 of 5  FEATURED RESULTS Cytogenetics - Technologies, Markets and Companies RNAi - Technologies, Markets and Companies Cell Therapy - Technologies, Markets and Companies Gene Therapy - Technologies, Markets and Companies Personalized Medicine - Scientific and Commercial Aspects   Sort by    Report Name ASC Report Name DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom RNAi Therapeutics 2008 Market Report   Select Biosciences Ltd, Nov 2007, Pages: 171 This is the latest RNAi-based Therapeutics Market. ... 575029, RNAi Therapeutics 2008 Market Report, This is the latest RNAi-based Therapeutics Market. ... Advances in RNAi--A Global Technology Assessment (Technical Insights)   Frost & Sullivan, Nov 2004 Transfecting RNAi into Target Cells Proves to be a Significant Challenge Delivering or transfecting ribonucleic acid interference (RNAi) into mammalian cell. ... Realizing the Promise of Therapeutic RNAi: Emerging Strategies for RNAi Delivery   Decision Resources, Inc., Jan 2008, Pages: 26 Introduction The discovery of RNA interference (RNAi) has renewed interest in developing nucleic acid drugs based on targeting messenger RNAs (mRNAs). This fie. ... RNAi/MicroRNA Market Report 2007   Select Biosciences Ltd, Feb 2007, Pages: 117 This report presents an industry analysis of the RNAi and microRNA markets in both qualitative and quantitative terms. ... RNAi industry SWOT analysis Chapter IV. ... U.S. RNAi Markets   Frost & Sullivan, May 2006 This Frost & Sullivan research service entitled US RNAi Markets provides revenue forecasts for individual market sectors as well as overall market, detailed m. ... RNAi: Broad Application, Expansive Opportunity, 2nd Edition   Drug and Market Development Publishing, Jan 2005, Pages: 326 RNAi is the hottest topic in biotechnology and is positioned to revolutionize research and drug discovery. The drug discovery market based on RNAi is projected. ... The Exploding RNAi Market & Future Direction Translating the Genome into a Large Market by 2009   Fuji-Keizai USA, Inc., Feb 2006, Pages: 130 317541, The Exploding RNAi Market & Future Direction Translating the Genome into a Large Market by 2009, Since its discovery in 1998 by two scientists, the ... The Outlook For RNAi: Accelerating Drug Discovery and the Development of RNAi Therapeutics   Business Insights, May 2005 323964, The Outlook For RNAi: Accelerating Drug Discovery and the Development of RNAi Therapeutics, While the human genome project has provided vast amounts of ... Outlook for RNAi, 2007: siRNA and miRNA in Biology, Diagnostics and Therapeutics   Business Insights, June 2007, Pages: 244 RNAi-based screens have provided new opportunities for the discovery and validation of novel therapeutic targets inareas such as cancer and infectious diseases ... Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi   Business Insights, April 2005, Pages: 186 Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi, is a new report which provides an in-depth. ... Optimizing Synthetic RNAi: Perspectives from the Pharmaceutical and Biotech Industry   BioInformatics, LLC, Nov 2006, Pages: 115 682688, Optimizing Synthetic RNAi: Perspectives from the Pharmaceutical and Biotech Industry, Overview Building upon the success of the 2004 report on RNA ... The Future of RNAi Therapeutics: Drug Pipelines and Prospects   Business Insights, Sep 2008, Pages: 253 659568, The Future of RNAi Therapeutics: Drug Pipelines and Prospects, "The total RNAi therapy market is estimated to value $580m by 2012. ... Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities   PharmaVision, July 2009, Pages: 225 This cutting edge & insightful report can be used to interpret & assess the potential of RNAi-based medicines. It provides opinions & market projections to: -. ... RNAi - Technologies, Markets and Companies   Jain PharmaBiotech, Nov 2009, Pages: 451 RNA interference (RNAi) or gene silencing involves the use of double stranded RNA (dsRNA). ... Various markets relevant to RNAi are analyzed from 2008 to 2018. ... Alnylam & Roche RNAi Therapeutics Strategic Alliance Agreement Call - Alnylam Pharmaceuticals, Inc. - Earnings Transcript   FactSet, July 2007 Alnylam & Roche RNAi Therapeutics Strategic Alliance Agreement Call - Alnylam Pharmaceuticals, Inc. - Earnings Transcript Monday, July 09, 2007 12:30 Correc. ... Sirna Therapeutics, Inc. - RNAI - Annual Report   Annual Reports Service 55689, Sirna Therapeutics, Inc. - RNAI - Annual Report, Research and Markets Annual Reports Service provides you with quick access to annual accounts and other ... RNAi - Industry Background and Company News Updates   DMS Data Systems 300225, RNAi - Industry Background and Company News Updates, Our Industry and Company News Updates are designed to provide a comprehensive list of all companies ... RNA Interference for Drug R&D: Applications, Alliances, Companies and WW Market to 2011   Takeda Pacific, July 2007, Pages: 131 RNA interference (RNAi) has been hailed in the science media as the hottest technical breakthroug. ... RNAi can also be used as a therapeutic agent. ... Progress in RNA-Based Therapeutics   Decision Resources, Inc., Aug 2005, Pages: 19 ... Business Implications - RNA-based technologies include antisense oligonucleotides (ASOs), RNA interference (RNAi), and microRNA (miRNA). ... Insights into Platform Technology and Early-Stage Pipeline Mergers and Acquisitions   Decision Resources, Inc., March 2009, Pages: 24 ... Therapeutic platforms: therapeutic antibodies, artificial protein scaffolds, RNAi therapeutics. - Target and lead discovery: RNAi ... Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   Next -   Last

		Top of page

All rights reserved. © Copyright 2009 Research and Markets0    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster